JCN Newswire
Read More

Eisai to Present Latest Data on Perampanel at the 76th American Epilepsy Society (AES) Annual Meeting

ruth
2 minutes

TOKYO, Nov 24, 2022 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. announced today that the company will have a total of 34 poster presentations, including the latest data on its in-house discovered and developed anti-epileptic agent (AED) perampanel (product name: Fycompa) at the 76th American Epilepsy Society Annual Meeting (AES 2022), to be held in Nashville, Tennessee and virtually from December 2-6, 2022.Key data Presentations for perampanel include the:- Results from a post hoc analysis of the phase III clinical trial (FREEDOM/342), which evaluated long-term efficacy of perampanel monotherapy by seizure type in the open-label extension (52 weeks) for epilepsy patients with focal-onset seizures (FOS), ≥ 12 years of age without prior treatment history (poster number: 2.228)- Real-world pooled analyses of perampanel for pediatric patients (poster number: 1.310),adolescent patients (poster number: 1.313) and elderly patients (poster number: 1.312)- Results from a post hoc analysis of two phase III open-label extension (OLEx) studies, Study 307 and Study 335 OLEx, evaluating the long-term efficacy and safety of adjunctive perampanel in a subgroup of older adult pat...

JCN Newswire
Read More

Eisai to Present Latest Data on Perampanel and E2730 at the 75th American Epilepsy Society Annual Meeting

ruth
2 minutes

TOKYO, Nov 30, 2021 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. announced today that the company will conduct a total of 42 poster presentations, including the latest data on its in-house discovered and developed anti-epileptic agent (AED) perampanel (product name: Fycompa) and in-house discovered and developed E2730, an investigational novel small compound for AED and the treatment for neurological diseases, at the 75th American Epilepsy Society Annual Meeting (AES2021), to be held in Chicago, Illinois and virtually from December 3 to 7, 2021. Major presentations regarding perampanel include poster presentations about the analysis results from the phase III clinical trial (FREEDOM/Study 342), which evaluated long-term efficacy and safety of the perampanel monotherapy in the open-label extension (52 weeks) for epilepsy patients with focal-onset seizures (FOS) from 12 to 74 years of age without prior treatment history (Poster number: 1.283). Additionally, an overview of phase III and other clinical studies (Poster number: 2.218) and a real-world pooled analysis of perampanel for elderly patients (Poster number: 1.215), will be presented. For E2730, a poster presentation wil...

SeaPRwire
Read More

2 men accused of tampering with election posters charged

aseanpr
2 minutes

SINGAPORE - Two men accused of tampering with election posters in separate incidents were charged in a district court on Wednesday (Nov 25). The two Singaporeans - Lim Song Huat, 48 and Constantine Paul, 51 - were charged with offences under the Parliamentary Elections Act. The general election in Singapore was held on July 10. Lim, who faces three charges, was along a service road in Woodlands Street 13at around 9.30am on July 3, during the campaigning period, when he allegedly used a black pen to draw a horizontal line across a People's Action Party (PAP) poster hung on a lamp post. He is also accused of using his hands to tear a second PAP poster about 15 minutes later. Lim is said to have then destroyed a third PAP poster by tearing it with his hands at around 9.47am. Paul, who faces two charges, allegedly removed two Progress Singapore Party (PSP) posters from lamp posts along Bukit Batok East Avenue 5 at around 8pm on June 30. In an earlier statement, the police said they had initiated investigations after officers came across an election poster belonging to the PSP at the bottom of a lamp post in Bukit Batok East Avenue 5 at about 1.50am on July 1. Later that day, the PSP lo...